The Israeli Phage Therapy Center (IPTC), led by two Hebrew University of Jerusalem professors, has used a bacteriophage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections in 16 patients. It has shown promising results with an 86.6% success … Continue reading →

Israel’s Team Prismatix – combining scientists at Israel’s Technion Institute and Bnai Zion Medical Center – has won a Discovery Award for its research into rapid diagnostics for antibiotic resistance. The awards are part of the UK Nesta Foundation’s Longitude … Continue reading →

Researchers at Israel’s Weizmann Institute have found new RNA-control switches (“ribo-switches) for genes encoding antibiotic resistance and discovered that these switches are actually “turned on” by the antibiotics themselves.  The switches could be turned off by future treatments. http://wis-wander.weizmann.ac.il/life-sciences/switching-antibiotic-resistance

Tel Aviv University Professor Udi Qimron has published in PNAS his research about bacterial viruses (phages) that attack bacteria. The phages transfer “edited” DNA into resistant bacteria to kill off resistant strains and make others more sensitive to antibiotics. Clinical … Continue reading →

Israel’s Mileutis (see here previously) is “bullish” about its Imilac peptide alternative to antibiotics in dairy cows. Imilac boosts the immune system to fight infections and doesn’t increase antibiotic resistance. The cows also produce more milk. Mileutis says the same … Continue reading →

An AI tool from Israel’s Technion Institute helps combat antibiotic resistance. It reduced ineffective antibiotics prescribed for urinary tract infections by 35%. The tool was trialed by Israel’s Maccabi Health Management Organization (HMO) and will now be used for other … Continue reading →

Israel’s Omnix (reported here previously) has been awarded €10.8 million in EU funding under the EIC Accelerator Programme, part of the EU’s Horizon 2020 research funding program. Omnix’s OMN6 peptide destroys the bacteria’s membrane, regardless of its resistance. https://www.calcalistech.com/ctech/articles/0,7340,L-3889749,00.html https://www.omnixmedical.com/omnix-medical-wins-e10-8m-in-eic-accelerator-funding/

Israel’s Omnix Medical (reported here previously( is developing novel antibiotic agents for the treatment of hospital-acquired infections involving resistant bacteria. Omnix has successfully completed lab testing and has now raised funding to allow it to commence human clinical trials. https://www.calcalistech.com/ctech/articles/0,7340,L-3868294,00.html … Continue reading →

Israeli biotech Mileutis has developed Imilac – designed to treat mastitis in cows by boosting their immune systems. Imilac is near the marketing stage and can replace the wide use of antibiotics for which resistance is growing and being passed … Continue reading →

Researchers at the Hebrew University of Jerusalem have developed an intravenous injection to fight hospital superbugs (bacteria resistant to most current antibiotics). They used nanotechnology to develop an injected form of mupirocin – which previously was just an antibiotic ointment. … Continue reading →